Aster DM Healthcare Limited — Updates, 31-01-2025: Press Release

Aster DM Healthcare reported robust financial results for the third quarter and the first nine months of FY25. Total revenue for 9M FY25 increased by 15% year-over-year (YoY) to INR 3,138 Cr, while Q3 FY25 revenue rose by 11% to INR 1,050 Cr. Operating EBITDA climbed 35% YoY to INR 613 Cr in 9M FY25, with margins improving to 19.5% from 16.6% last year. For Q3, Operating EBITDA grew 20% YoY to INR 202 Cr, with margins at 19.3%. Net profit after excluding one-time costs surged by 65% YoY to INR 251 Cr for 9M FY25. The company declared an interim dividend of INR 4 per share. Aster DM Healthcare aims to expand its bed capacity to over 6,800 by FY27, supported by strategic growth initiatives, including a significant merger with Quality Care India Limited, pending regulatory approvals. The positive momentum and strong core business performance underline a favorable outlook for investors, marked by consistent growth across operations and successful capacity enhancements.